PUMA BIOTECHNOLOGY, INC. (PBYI) Operating cash flow 2016–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$41.8MFY2025 · since FY2016: -$141.7M → $41.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $41.8M | +7.4% |
| FY2024 | $38.9M | +44.1% |
| FY2023 | $27.0M | +270.7% |
| FY2022 | -$15.8M | -176.6% |
| FY2021 | $20.6M | +2571.4% |
| FY2020 | $773,000 | -96.5% |
| FY2019 | $22.4M | +192.8% |
| FY2018 | -$24.1M | +86.0% |
| FY2017 | -$172.5M | -21.7% |
| FY2016 | -$141.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice